A Preliminary Investigation of Lamotrigine for Cocaine Abuse in HIV-Seropositive Patients

References

• McGinty J. F. Introduction to the role of excitatory amino acids in the actions of abused drugs: A symposium presented at the 1993 annual meeting of the College on Problems of Drug Dependence. Drug Alcohol Depend 1995; 37: 91–94
   PubMedGoogle Scholar
• Leach M. J., Marden C. M., Miller A. A. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia 1986; 27: 490–497
   PubMed Web of Science ®Google Scholar
• Meldrum B., Leach M. The mechanisms of action of lamotrigine. Reviews of Contemporary Pharmacotherapy 1994; 5: 107–114
   Google Scholar
• Miller A. A., Wheatley P., Sawyer D. A., Baxter M. G., Roth B. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: I. Anticonvulsant profile in mice and rats. Epilepsia 1986; 27: 483–489
   PubMedGoogle Scholar
• Cornish J. W., Maany I., Fudala P. J., Neal S., Poole S. A., Volicelli P., O'Brien C. P. Carbamazepine treatment for cocaine dependence. Drug Alcohol Depend 1995; 38(3)221–227
   PubMedGoogle Scholar
• Halikas J. A., Kuhn K. L., Crea F. S., Carlson G. A., Crosby R. Treatment of crack cocaine use with carbamazapine. Am. J. Drug Alcohol Abuse 1992; 18(1)45–56
   PubMed Web of Science ®Google Scholar
• Xie S., Landaster B., Peakman T. Interaction to the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na channels and with native Na channels in rat hippocampal neurones. Pflugers Archive‐European Journal of Physiology 1995; 430: 437–446
   PubMed Web of Science ®Google Scholar
• Jones‐Himble S. A., Morgan P. F., Cooper B. R. The novel anticonvulsant lamotrigine prevents dopamine depletion in C57 black mice in the MPTP animal model of parkinson's disease. Life Sciences 1993; 54: 245–252
   Google Scholar
• Brodie M. J. Lamotrigine versus other antiepileptic drugs: A star rating system is born. Epilepsia 1994; 35(Suppl 5)S41–S46
   PubMed Web of Science ®Google Scholar
• Fitton A., Gao K. L. Lamotrigine: An update of its pharmacology and therapeutic use in epilepsy. Drug Evaluation 1995; 50(4)691–713
   Google Scholar
• Yuen A. W. C. Lamotrigine vs. carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsia 1994; 35(Suppl 8)31
   Google Scholar
• Majewska M. D. Cocaine addiction as a neurological disorder: Implications for treatment. Neurotoxicity and Neuropathology Associated with Cocaine Abuse, M. D. Majewska. NIDA Research Monograph, Washington, D.C. 1996; Vol. 163: 1–26
   Google Scholar
• Kosten T. R., Malison R., Wallace E. Neuropsychological abnormalities in cocaine abusers: Possible correlates in SPECT neuroimaging. Neurotoxicity and Neuropathology Associated with Cocaine Abuse, M. D. Majewska. NIDA Research Monograph, Washington, D.C. 1996; Vol. 163: 175–192
   Google Scholar
• Lipton S. A., Rosenberg P. A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med 1994; 330(9)613–622
   PubMed Web of Science ®Google Scholar
• Wood E. R., Coury A., Blaha C. D., Phillips A. G. Extracellular dopamine in the rat striatum during ischemia and reperfusion as measured by in vivo electrochemistry and in vivo microdialysis. Brain Research 1992; 591: 151–159
   PubMedGoogle Scholar
• Holman B. I., Carvalho P. A., Mendelson J., Teoh S. K., Nardin R., Hallgring E., Hebben N., Johnson K. A. Brain perfusion is abnormal in cocaine‐dependent polydrug users: A study using technetium‐99m‐HMPAO and ASPECT. Journal of Nuclear Medicine 1991; 32: 1206–1210
   PubMed Web of Science ®Google Scholar
• Herning R. I., Glover B. J., Koeppl B., Weddington W., Jaffe J. H. Cognitive deficits in abstaining cocaine abusers. Residual Effects of Abused Drugs on Behavior, J. W. Spencer, J. J. Boren. NIDA Research Monograph, Washington, D.C. 1990; Vol. 101
   Google Scholar
• O'Malley S., Adamse M., Heaton R. K., Gawin F. H. Neuropsychological impairment in chronic cocaine abusers. Am. J. Drug Alcohol Abuse 1992; 18(2)131–144
   PubMed Web of Science ®Google Scholar
• Smith S. E., Meldrum B. S. Cerebroprotective effect of lamotrigine after focal ischemia in rats. Stroke 1995; 26(1)117–121
   PubMed Web of Science ®Google Scholar
• Wiard R. P., Dickerson M. C., Beek O., Norton R., Cooper B. R. Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia. Stroke 1995; 26(3)466–472
   PubMed Web of Science ®Google Scholar
• McGreer E. G., Zhu S. G. Lamotrigine protects against kainate but not ibotenate lesions in rat striatum. Neuroscience Letter 1990; 112: 348–351
   PubMedGoogle Scholar
• Freed W. J. Glutamatergic mechanisms mediating stimulant and antipsychotic drug effects. Neurosci. and Biobehav. Rev 1994; 18(1)111–120
   PubMedGoogle Scholar
• Moghaddam R. Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine: Implications for tonic influence of glutamate on dopamine release. Synapse 1994; 18: 337–342
   PubMed Web of Science ®Google Scholar
• Pap A., Bradberry C. W. Excitatory amino acid antagonists attenuate the effects of cocaine on extracellular dopamine in the nucleus accumbens. J. Pharmacol. Exp. Ther 1995; 274(1)127–133
   PubMedGoogle Scholar
• Pulvirenti L., Sung R., Koob G. F. Microinjection of NMDA but not quisqualate receptor antagonists into the nucleus accumbens modulates intravenous cocaine self‐administration in rats. Soc. Neurosci. Abstr 1989; 15: 1098
   Google Scholar
• Kalivas P. W. Interactions between dopamine and excitatory amino acids in behavioral sen‐sitization to psychostimulants. Drug Alcohol Depend 1995; 37: 95–100
   PubMed Web of Science ®Google Scholar
• Basic Neurobiology of Cocaine: Actions Within the Mesolimbic Dopamine System, D. Beitner‐Johnson, E. J. Nestler. Guilford Press, New York 1992, ‘Clinician's Guide to Cocaine Addiction’
   Google Scholar
• Pakesch G., Loimer N., Grunberger J., Pfersmann D., Linzmayer L., Mayerhofer S. Neuropsychological findings and psychiatric symptoms in HIV‐1 infected and noninfected drug users. Psychiatry Res 1992; 41: 163–177
   PubMed Web of Science ®Google Scholar
• McKegney F. P., O'Dowd M. A., Feiner C., Selwyn P., Drucker E., Friedland G. H. A prospective comparison of neuropsychologic function in HIV‐seropositive and seronegative methadone‐maintained patients. AIDS 1990; 4: 565–569
   PubMed Web of Science ®Google Scholar
• Woods S. W., O'Malley S. S., Martini B. L., McDougle C. J., Price L. H., Krystal J. H., Hoffer P. B., Kosten T. R. SPECT regional cerebral blood flow and neuropsy‐chological testing in non‐demented HIV‐positive drug abusers. Prog. Neuropsychopharmacol. Bio. Psychiatry 1991; 15: 649–662
   PubMedGoogle Scholar
• Barks J. D. E., Sun R., Malinak C., Silverstein F. S. gp120, an HIV‐1 protein, increases susceptibility to hypoglycemic and ischemic brain injury in perinatal rats. Exp. Neural 1995; 132: 123–133
   PubMed Web of Science ®Google Scholar
• Pellegrini J. W., Upton S. A. Delayed administration of memantine prevents N‐me‐thyl‐D‐aspartate receptor‐mediated neurotoxicity. Ann. Neurol 1993; 33: 403–407
   PubMed Web of Science ®Google Scholar
• Larrat E. P., Zierler S. Entangled epidemics: Cocaine use and HIV disease. J. Psychoactive Drugs 1993; 25(3)207–220
   PubMed Web of Science ®Google Scholar
• Camacho L. M., Brown B. S., Simpson D. D. Psychological dysfunction and HIV/AIDS risk behavior. J. of Acquired Immune Deficiency Syndromes and Human Retrovirology 1996; 11(2)198–202
   PubMedGoogle Scholar
• Fagnou D. D. T.J.M. The biochemistry of learning and memory. Mol. Cell. Biochem 1995; 149–150: 279–286
   PubMedGoogle Scholar
• Binnie C. D. Cognitive impairment: Is it inevitable?. Seizure 1994; 3(Supp A)17–22
   PubMedGoogle Scholar
• Cohen A. J., Ashby L., Crowley D., Land G., Peck A. W., Miller A. A. Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam. Br. J. Pharmacol 1985; 20: 619–629
   Google Scholar
• Hamilton M. J., Cohen A. F., Yuen A. W. C. Carbamazepine and lamotrigine in healthy volunteers: Relevance to early tolerance and clinical trial dosage. Epilepsia 1993; 34: 166–173
   PubMed Web of Science ®Google Scholar
• Avants S. K. Risk Reduction Therapy (RRT) for HIV‐positive injection drug users. 1996, Unpublished treatment manual
   Google Scholar
• First M., Spitzer R. L., Gibbon M., Williams J. Structured Clinical Interview for DSM‐IV Axis I Disorders—Patient Edition (SCID‐I/P‐Version 2.0). Biometrics Research Department, New York State Psychiatric Institute, New York 1996, 722 W. 168th Street, NY 10032
   Google Scholar
• McLellan A. T., Luborksy L., Woody G. E., O'Brien C. P. An improved diagnostic instrument for substance abuse patients: The Addiction Severity Index. J. Nerv. Ment. Dis 1980; 168: 26–33
   PubMed Web of Science ®Google Scholar
• Beck A. T., Ward C. H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961; 4: 561–571
   PubMed Web of Science ®Google Scholar
• Spielberger C. D., Gorsuch R. L., Lushene R. E. The State‐Trait Anxiety Inventory Test Manual. Consulting Psychologists Press, Palo Alto, California 1970
   Google Scholar
• Wechsler D. WAIS‐R Manual. Psychological Corporation, New York 1981
   Google Scholar
• Rey A. L'examen Clinique en Psychologie. Presses Universitaires de France, Paris 1964
   Google Scholar
• Russell E. W. A multiple scoring method for the assessment of complex memory functions. J. Consult. Clin. Psychol 1975; 43: 800–809
   Web of Science ®Google Scholar
• Gronwall D. M. A. Paced auditory serial‐addition task: A measure of recovery from concussion. Perceptual and Motor Skills 1977; 44: 367–373
   PubMed Web of Science ®Google Scholar
• Benton A. L., Hamsher K. Multilingual Aphasia Examination. University of Iowa, Iowa City 1976
   Google Scholar
• Army. Army Individual Test Battery. Manual of Directions and Scoring. War Department, Adjutant General's Office, Washington, D.C. 1994
   Google Scholar
• Poklis A. Evaluation of Tdx cocaine metabolite assay. J. Anal. Toxicol 1987; 11: 228–230
   PubMed Web of Science ®Google Scholar
• Pellock J. M. The clinical efficacy of lamotrigine as an antiepileptic drug. Neurology 1994; 44(Suppl 8)829–835
   PubMedGoogle Scholar
• Mendelson J. H., Holman B. I., Teoh S. W., Levin J., Mello N. K. Buprenorphine treatment improves brain perfusion abnormalities in men with concurrent cocaine and heroin dependence: A SPECT brain imaging analysis. Problems of Drug Dependence, 1994, L. Harris. NIDA Research Monograph Series, Washington, D.C. 1995; Vol. 153
   Google Scholar
• Calabrese J. R., Faterni S. H., Woyshville M. J. Antidepressant effects of lamotrigine in rapid cycling bipolar disorder. Am. J. Psychiatry 1996; 153: 1236
   PubMed Web of Science ®Google Scholar
• Mervaala E., Koivisto K., Hanninen T. Electrophysiological and neuropsychological profiles of lamotrigine in young and age‐associated memory impairment subjects. Neurology 1995; 46(Suppl 4)A259
   Google Scholar
• Lezak M. Neuropsychological Assessment. Oxford University Press, New York 1983
   Google Scholar